Discussion about this post

User's avatar
I, Bayes's avatar

Two things make my stance more cautious than this article's.

First, a part of MELI's business that rarely gets discussed: float. They hold an enormous amount of money that isn't theirs and put it to work funding growth, much like Buffett did with insurance premiums. But regulators are increasingly aggressive about float, requiring more and more of that cash to sit restricted in government bonds or similar instruments.

Second, an 11% discount rate is still too favorable given the equity risk premium in Latin America. Damodaran estimates total ERP for Argentina at 13.94%. For the US it's 4.46%. Add even two points to the discount rate and a big part of terminal value disappears.

I go into both points and run scenario analysis here: https://theinvestlog.com/p/mercado-libre-reverse-dcf-pricing. Would love your thoughts.

Michael | Stock Spotlight's avatar

Nice article! I'm working on a valuation approach combing your normalized OCF approach with Hated Moats' SOTP approach. Will give you a shout out in my upcoming podcast episode with Shivam from X talking about his trip to Brazil and doing a MELI update.

13 more comments...

No posts

Ready for more?